Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBTD1 | Q05BQ5 | 3/20 | 0.41 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.41 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16281659 | 1.00 | MBTD1 (0.41) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| Hydrochloric Acid SCHEMBL4068811 | 0.95 | MBTD1 (0.39) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL13344223 | 0.92 | MBTD1 (0.46) | MBTD1L3MBTL3EPAS1L3MBTL1 | |
| Formic Acid SCHEMBL27743045 | 0.88 | MBTD1 (0.41) | MBTD1L3MBTL3L3MBTL1EPHX1 | |
| SCHEMBL26720816 | 0.87 | EPAS1 (0.42) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL11570313 | 0.87 | EPAS1 (0.42) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL8603609 | 0.87 | EPAS1 (0.42) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL4783327 | 0.87 | EPAS1 (0.42) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL11570310 | 0.87 | EPAS1 (0.42) | MBTD1L3MBTL3EPAS1L3MBTL1OPRM1 | |
| SCHEMBL3719347 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111386118-A | Combination pharmaceutical agents as RSV inhibitors | 英安塔制药有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-109851610-B | Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonists | 赫普泰雅治疗有限公司 | 2021-09-21 | — | — | CN | disclosed |
| EP-2475643-A1 | NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011026959-A1 | NOVEL ETHANE DIAMINE HEPCIDIN ANTAGONISTS | VIFOR (INTERNATIONAL) AG (CH) | 2011-03-10 | — | — | WO | disclosed |
| EP-1060785-B1 | Interfacially polymerized, bipiperidine-polyamide membranes for reverse osmosis and/or nanofiltration and process for making the same | HYDRANAUTICS (US) | 2006-04-05 | — | — | EP | disclosed |
| US-6464873-B1 | POLYFUNCTIONAL AROMATIC OR CYCLOALIPHATIC ACYL HALIDE REACTANT; HIGH FLUX RATES AND LOW PRESSURES WITH HIGH SULFATE REJECTION. | HYDRANAUTICS | 2002-10-15 | — | — | US | disclosed |
| US-6303614-B1 | FOR THERAPY PSYCHOTIC DISORDER SELECTED FROM DEPRESSION, ANXIETY OR PSYCHOSIS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-10-16 | — | — | US | disclosed |
| EP-1060785-A1 | Interfacially polymerized, bipiperidine-polyamide membranes for reverse osmosis and/or nanofiltration and process for making the same | HYDRANAUTICS (US) | 2000-12-20 | — | — | EP | disclosed |
| US-5215967-A | AMINOACID DERIVATIVES INHIBITING RENIN | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-06-01 | — | — | US | disclosed |